April 24, 2018 2:05 AM ET


Company Overview of Unimedic AB

Company Overview

Unimedic AB engages in the development, manufacture, and distribution of pharmaceuticals in Europe. It offers a range of non-licensed, extemporaneous, and licensed pharmaceuticals for anesthesiology/intensive care, gastroenterology, immunoglobulins/transplant, and drug addiction treatment therapy areas. The company also provides contract development and manufacturing services for sterile and non-sterile liquid pharmaceuticals, including formulation development, method development, and validation and stability studies at ICH-conditions. In addition, it supplies imported pharmaceuticals to pharmacies; and provides repackaging services for medical products, dietary supplements, cosmetics/medica...

Storjordenvägen 2

Matfors,  864 31


Founded in 1992


46 0 60 51 50 00


46 0 60 51 50 11

Key Executives for Unimedic AB

Chief Executive Officer
Age: 48
Chief Financial Officer
Chief Operating Officer and CDMO
Head of Specialty Pharma
Head of Cross Pharma
Compensation as of Fiscal Year 2017.

Unimedic AB Key Developments

Martindale Pharma Announces Extension of Licensing Agreement with Unimedic AB to Include Emergency Care Product Portfolio

Martindale Pharma announced a new licensing agreement with its strategic partner Unimedic AB for its Emergency Care sterile ampoule products in Sweden, Denmark, Norway and Finland. Under the new agreement, Unimedic AB will launch three undisclosed products. This builds on the long term relationship between the companies in Scandinavia which has seen Unimedic AB successfully commercialise a Martindale Pharma adrenaline ampoule product in Sweden. Financial terms of the agreement were not disclosed. The Companies will work together on regulatory and supply chain activities leading to the launch of the products.

Altia Plc and Unimedic AB Announce Agreement on Cooperation

Altia Plc and Unimedic AB have agreed to start a cooperation regarding the production of Swedish Aquavits and spiced spirits. Altia and Unimedic will invest into production equipment and new factory building. The production process includes distillation, extraction and maturation of Swedish Aquavits and spiced spirits. The factory is located in Matfors, Sundsvall. The agreement covers all Altia's Swedish Aquavits and spiced spirits (kryddat brannvin) O.P. Anderson, Skane Akvavit, Hallands Flader, Baska Droppar, Gammal Norrlands Akvavit, Ostgota Sadesbrannvin, Lacko Slottsaquavit, Herrgards Aquavit, Ranas Brannvin, Nykpingsbrannvin, Svartvinbarsbrannvin and Ortagardsbrannvin. Altia relocates the production of the Swedish Aquavits and spiced spirits and secures the continuation of the Swedish origin. The construction of the new distillery in Matfors, Sundsvall has started and it is planned to be ready for production early 2017. The plant will be certified for organic production.

Similar Private Companies By Industry

Company Name Region
Abunon AB Europe
Aditech Pharma AB Europe
Antarctic Pharma Europe
Apotek Produktion & Laboratorier AB Europe
Appetite Control Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Unimedic AB, please visit www.unimedic.se. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.